Treating gum disease during AFib blanking period could reduce recurrence risk

Study evaluates whether treating periodontitis during the blanking period after atrial fibrillation (AF) ablation reduces AF recurrence, revealing that comprehensive periodontal care may significantly diminish recurrence rates by addressing inflammation linked to periodontitis.

Ex-Metacrine chief Preston Klassen recharges at microRNA biotech; Allogene begins search for a CFO

→ Preston Klassen has mapped out his next destination as president and R&D chief of microRNA developer Regulus Therapeutics. Klassen was the CEO of Metacrine,

June 17, 2023

Illinois Cannabis Sales Increase Slightly in October

Illinois released sales figures for adult-use cannabis in October today, a bit later than normal. They were up 4.2% sequentially to $142.3 million. On a per-day basis, sales

December 4, 2024

Cidara buys back rights to flu therapy from J&J for $85m

Share this article Cidara also closed a private placement of preferred stock worth $240m to buy back the rights for CD388 and advance its development.

April 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.